Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding a pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
183
Frequently Asked Questions
What is Market Cap of Entrada Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Entrada Therapeutics Inc market cap is $201.22M.
What is the 52-week high for Entrada Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Entrada Therapeutics Inc 52 week high is $21.79 as of September 09, 2025.
What is the 52-week low for Entrada Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Entrada Therapeutics Inc 52 week low is $4.93 as of September 09, 2025.
What is Entrada Therapeutics Inc stock price today?
Entrada Therapeutics Inc stock price today is $5.28.
What was Entrada Therapeutics Inc stock price yesterday?
Entrada Therapeutics Inc stock price yesterday was $5.29.
What is the PE ratio of Entrada Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Entrada Therapeutics Inc’s P/E ratio is -2.96.
What is the Price-to-Book ratio of Entrada Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Entrada Therapeutics Inc P/B ratio is 0.5302.
What is the 50-day moving average of Entrada Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Entrada Therapeutics Inc 50-day moving average is $6.08.
How many employess does Entrada Therapeutics Inc has?
